Für Windows / Linux: Mit diesen Tastenkombinationen können Sie die Schriftgröße anpassen:
Für Mac: Mit diesen Tastenkombinationen können Sie die Schriftgröße anpassen:
Sie sind hier:
Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002
Phase 1-Studie „Open-label, uncontrolled clinical trial to evaluate the safety and efficacy of autologous fibrin-cultured epidermal grafts containing epidermal stem cells genetically modified for restoration of epidermis in patients with junctional epidermolysis bullosa“ (EudraCT number 2022-001780-27; Coordinating investigator: Prof. Dr. Holm Schneider)
Phase 2-Studie „A prospective, open-label, genotype-match controlled, multicenter clinical trial to investigate the efficacy and safety of intra-amniotic ER004 as a prenatal treatment for male subjects with X-linked hypohidrotic ectodermal dysplasia (XLHED)“ (EudraCT number 2021-002532-23; Coordinating investigator: Prof. Dr. Holm Schneider).
